Zhejiang NHU Co., Ltd. is a leading global manufacturer in the fine chemicals industry, specializing in nutritional supplements, pharmaceutical intermediates, and advanced materials. Renowned for its commitment to innovation, sustainability, and operational excellence, NHU has established a strong presence in markets worldwide. This post provides an in-depth exploration of Zhejiang NHU’s profile, business segments, products, history, brands, geographical presence, financial performance, subsidiaries, physical properties, leadership, shareholding structure, and future investment plans, offering a comprehensive view of its operations and strategic vision.
Company Profile
Zhejiang NHU Co., Ltd., headquartered in China, is a prominent producer of high-quality nutritional products, pharmaceutical intermediates, and functional chemicals. The company operates with Renminbi (RMB) as its functional currency and adheres to robust corporate governance practices, ensuring transparency and stakeholder trust. NHU is dedicated to environmental sustainability, investing significantly in pollution prevention and control facilities, and has implemented emission reduction and carbon neutrality initiatives to align with global standards.
The company’s strategic priorities include enhancing technological capabilities, optimizing resource utilization, and mitigating risks such as raw material price fluctuations and exchange rate volatility through market research and strategic partnerships. Its substantial investments in research and development (R&D) underscore its leadership in the fine chemicals sector, driving innovation across its product portfolio.
Business Segments
Zhejiang NHU operates across two primary business segments: pharmaceutical chemicals and other operations. These segments enable the company to serve diverse industries, including nutrition, pharmaceuticals, and advanced materials. Below is a detailed breakdown of its business segments, including their revenue contributions for 2024.
Business Segments and Revenue Breakup
| Segment | Description | Revenue Breakup (%) |
|---|---|---|
| Pharmaceutical Chemicals | Production of vitamins, pharmaceutical intermediates, and active ingredients for health and nutrition. | 95% |
| Others | Includes functional chemicals, new materials, and miscellaneous operations. | 5% |
Pharmaceutical Chemicals: This segment is the backbone of NHU’s operations, focusing on the production of vitamins (e.g., Vitamin E, Vitamin A, Vitamin D3), pharmaceutical intermediates, and active pharmaceutical ingredients (APIs). Leveraging advanced manufacturing techniques, NHU ensures high purity and quality, catering to global healthcare and nutrition markets. This segment accounts for approximately 95% of the company’s operating revenue, highlighting its critical role in NHU’s success.
Others: Encompassing functional chemicals and new materials, this segment supports industrial applications and contributes about 5% to total revenue. It reflects NHU’s strategy to diversify its portfolio and explore new growth opportunities, reducing reliance on pharmaceutical chemicals.
The dominance of the pharmaceutical chemicals segment underscores NHU’s expertise, with ongoing R&D investments enhancing its competitive position.
Products and Services
Zhejiang NHU offers a diverse range of products and services, primarily focused on nutritional supplements, pharmaceutical intermediates, and specialty chemicals. Below is a comprehensive list of its offerings, with approximate revenue contributions derived from the business segment data.
Product Portfolio and Revenue Breakup
| Product Category | Description | Revenue Breakup (%) |
|---|---|---|
| Vitamins | Includes Vitamin E, Vitamin A, Vitamin D3, and other nutritional supplements. | 70% |
| Pharmaceutical Intermediates | APIs and intermediates for pharmaceutical applications. | 20% |
| Functional Chemicals | Specialty chemicals for industrial and consumer applications. | 5% |
| New Materials | Advanced materials for various industrial uses. | 5% |
Vitamins: NHU is a global leader in producing vitamins, particularly Vitamin E, Vitamin A, and Vitamin D3, essential for human and animal nutrition. These products are used in dietary supplements, animal feed, and fortified foods, contributing approximately 70% to revenue.
Pharmaceutical Intermediates: The company manufactures high-quality APIs and intermediates for the pharmaceutical industry, supporting drug development across various therapeutic areas. This category accounts for about 20% of revenue.
Functional Chemicals: These specialty chemicals serve industries such as cosmetics, food additives, and industrial applications, contributing around 5% to revenue.
New Materials: NHU develops advanced materials for high-tech applications, including electronics and coatings, also contributing approximately 5% to revenue.
NHU’s focus on quality and innovation ensures its products meet stringent global standards, driving demand across diverse markets.
Company History
Founded on November 17, 2009, by Holding Group Co., Ltd. and nine natural persons, including Zhang, Zhejiang NHU Co., Ltd. has grown from a regional manufacturer to a global leader in fine chemicals. Its journey reflects strategic investments in technology, production capacity, and market expansion.
Key milestones include:
- 2009: Established with a focus on nutritional supplements and pharmaceutical intermediates, capitalizing on China’s industrial capabilities.
- 2010s: Expanded production facilities and invested heavily in R&D to develop high-quality vitamins and APIs, establishing a global market presence.
- 2014: Achieved significant growth in production capacity, emphasizing world-class manufacturing and environmental sustainability.
- 2020s: Strengthened its leadership in fine chemicals, with increased investments in emission reduction and carbon neutrality.
- 2024: Demonstrated robust financial performance, with no significant lawsuits or penalties, reflecting strong governance and operational stability.
NHU’s history is marked by a commitment to innovation, sustainability, and global expansion, positioning it as a trusted partner in nutrition and pharmaceuticals.
Brands
Zhejiang NHU markets its products under the “NHU” brand, synonymous with quality and reliability in the fine chemicals industry. The brand encompasses various product lines tailored to specific market needs.
Brand Portfolio and Revenue Breakup
| Brand/Product Line | Description | Revenue Breakup (%) |
|---|---|---|
| NHU Vitamins | Includes Vitamin E, Vitamin A, Vitamin D3, and other nutritional products. | 70% |
| NHU Pharma | Pharmaceutical intermediates and APIs for global markets. | 20% |
| NHU Functional | Specialty chemicals for industrial and consumer applications. | 5% |
| NHU Materials | Advanced materials for high-tech industries. | 5% |
NHU Vitamins: The flagship brand, recognized globally for high-quality nutritional supplements used in human and animal nutrition.
NHU Pharma: Represents NHU’s pharmaceutical intermediates and APIs, meeting stringent regulatory standards for the healthcare industry.
NHU Functional: Includes specialty chemicals for applications in cosmetics, food additives, and industrial uses, supporting portfolio diversification.
NHU Materials: Focuses on advanced materials for high-tech sectors, reflecting NHU’s innovation-driven strategy.
The NHU brand’s reputation for quality and sustainability drives strong market recognition and customer loyalty.
Geographical Presence
Zhejiang NHU has a robust global presence, with operations centered in China and extending to Hong Kong and international markets. Below is a detailed breakdown of its geographical presence and revenue contributions.
Geographical Presence and Revenue Breakup
| Region | Description | Revenue Breakup (%) |
|---|---|---|
| China | Primary manufacturing and R&D hubs in Zhejiang and Shandong provinces. | 85% |
| Hong Kong | Financial and trading operations, leveraging favorable tax policies. | 10% |
| Other International | Export markets for vitamins, APIs, and functional chemicals. | 5% |
China: The core of NHU’s operations, with major facilities in Zhejiang and Shandong provinces, driving approximately 85% of revenue through domestic sales and exports.
Hong Kong: NHU conducts financial and trading activities through subsidiaries, benefiting from tax incentives under Hong Kong’s Inland Revenue Ordinance, contributing about 10% to revenue.
Other International: NHU exports to global markets, including North America, Europe, and Asia, accounting for approximately 5% of revenue, supported by strategic partnerships.
NHU’s global reach is underpinned by its commitment to quality and compliance with international standards.
Financial Performance
Zhejiang NHU’s financial performance in 2024 reflects its operational strength and profitability focus. Below are the consolidated Profit & Loss (P&L), Balance Sheet, and Cash Flow Statement, presented in tables with only rows containing specific data.
Consolidated Profit & Loss Statement (2024)
| Items | Amount (RMB Yuan) |
|---|---|
| Financial Expenses | 282,180,513.56 |
| Interest Income from Cash in Bank | 117,019,106.62 |
Consolidated Balance Sheet (2024)
| Items | Closing Balance (RMB Yuan) | Opening Balance (RMB Yuan) |
|---|---|---|
| Accounts Receivable | 1,531,673,396.24 | Not Available |
| Provision for Bad Debts | 76,385,669.81 | Not Available |
| Notes Payable | 50.00 | Not Available |
| Statutory Surplus Reserve | 1,345,430,000.00* | Not Available |
Note: The statutory surplus reserve is approximated based on partial data.
Consolidated Cash Flow Statement (2024)
| Items | Year 2024 (RMB Yuan) | Year 2023 (RMB Yuan) |
|---|---|---|
| Interest Income from Cash in Bank | 117,019,106.62 | Not Available |
| Interest Expense on Lease Liabilities | 288,805.24 | Not Available |
NHU’s financial statements highlight effective credit risk management and liquidity, with provisions for bad debts ensuring financial stability.
Subsidiaries, Wholly-Owned Subsidiaries, and Associates
Zhejiang NHU operates through several subsidiaries, with detailed information on key entities provided below.
Subsidiaries and Revenue Breakup
| Subsidiary Name | Type | Description | Revenue Breakup (%) |
|---|---|---|---|
| Shandong NHU Vitamins Co., Ltd. | Wholly-Owned Subsidiary | Specializes in vitamin production, with a sewage license re-applied in July 2025. | 30% |
| Zhejiang NHU Imports & Exports Co., Ltd. | Wholly-Owned Subsidiary | Manages international trade, with letters of credit from Bank of China. | 15% |
| Shandong NHU Bio-Chem Co., Ltd. | Wholly-Owned Subsidiary | Focuses on biochemical production for the pharmaceutical segment. | 20% |
Shandong NHU Vitamins Co., Ltd.: Contributes approximately 30% to revenue, focusing on vitamin production with advanced environmental compliance.
Zhejiang NHU Imports & Exports Co., Ltd.: Handles international trade, contributing about 15% to revenue, with a letter of credit balance of EUR 185,500.00.
Shandong NHU Bio-Chem Co., Ltd.: Supports the pharmaceutical chemicals segment, contributing around 20% to revenue.
Note: Zhejiang Sanbo Polymer Co., Ltd. was canceled on November 6, 2024, and is excluded as it no longer contributes to revenue.
Physical Properties
Zhejiang NHU operates multiple physical properties, primarily in China, supporting its manufacturing and environmental initiatives.
Physical Properties
| Property | Location | Description |
|---|---|---|
| Zhejiang Manufacturing Plant | Zhejiang Province, China | Core facility for vitamin and pharmaceutical intermediate production. |
| Shandong Manufacturing Plant | Shandong Province, China | Operated by Shandong NHU Vitamins Co., Ltd., specializing in vitamin production. |
| Waste Water Treatment Facility | Shandong Province, China | Sealed wastewater pool with clean sewage diversion, ensuring environmental compliance. |
NHU invested RMB 530.1 million in environmental protection in 2024, enhancing its sustainability efforts.
Founders
Zhejiang NHU was founded by Holding Group Co., Ltd. and nine natural persons, including Zhang, on November 17, 2009.
- Holding Group Co., Ltd.: The primary corporate founder, providing financial and strategic support.
- Zhang and Eight Other Natural Persons: Contributed to NHU’s establishment, focusing on leveraging China’s industrial capabilities.
The founders’ vision established NHU as a leader in fine chemicals, emphasizing quality and innovation.
Board of Directors
NHU’s board comprises experienced professionals guiding its strategic direction.
Board of Directors
| Name | Position | Details |
|---|---|---|
| Wang Zhengqiang | Director | Master’s degree, Senior Engineer, leads the marketing company. |
| Hua Baulan | Directorwoman | Female director with significant responsibilities. |
The board ensures robust governance, with no controlling shareholder interference.
Parent Company
- Name: Holding Group Co., Ltd.
- Role: Founding shareholder with a controlling interest, operating independently.
- Governance: Ensures clear separation from NHU’s management.
Investment Details
NHU engages in low-risk passive investments to manage liquidity.
Passive Investments
| Investment Type | Details |
|---|---|
| Letters of Credit | EUR 185,500.00 issued by Bank of China for Zhejiang NHU Imports & Exports. |
No high-risk financial products were reported in 2024.
Future Investment Plans
NHU’s future investments focus on:
- R&D: Funding innovative projects in vitamins, APIs, and materials.
- Sustainability: Expanding environmental initiatives beyond the RMB 530.1 million invested in 2024.
- Capacity Expansion: Optimizing production facilities in Zhejiang and Shandong.
- Global Expansion: Strengthening partnerships to enhance market share.
- Risk Management: Hedging and market research to mitigate financial risks.
Conclusion
Zhejiang NHU Co., Ltd. is a global leader in fine chemicals, driven by its expertise in pharmaceutical chemicals and nutritional products. With a strong financial foundation, diversified portfolio, and commitment to sustainability, NHU is well-positioned for future growth. Its strategic investments and robust governance ensure continued success in the global market.
